Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPD1 | P10809 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11565066 | 0.82 | SLC1A3 (0.31) | HSPD1BLMHSPE1 | |
| SCHEMBL11432708 | 0.77 | MEN1 (0.36) | — | |
| SCHEMBL27561061 | 0.77 | — | — | |
| SCHEMBL5257823 | 0.76 | MEN1 (0.30) | — | |
| SCHEMBL28944444 | 0.73 | CES1 (0.39) | — | |
| SCHEMBL8747412 | 0.73 | — | — | |
| SCHEMBL6630941 | 0.72 | TDP1 (0.37) | HSPD1BLMHSPE1 | |
| SCHEMBL1201912 | 0.72 | SLC22A6 (0.30) | — | |
| SCHEMBL28161504 | 0.72 | CHRM1 (0.35) | — | |
| SCHEMBL1122815 | 0.71 | HSPD1 (0.34) | HSPD1BLMHSPE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0912467-B1 | ASYMMETRIC HYDROGENATION METHOD OF A KETONIC COMPOUND AND DERIVATIVE | RHODIA CHIMIE SA (FR) | 2002-04-24 | — | — | EP | claimed |
| EP-4578861-A1 | NOVEL TRICYCLIC HETEROCYCLIC CARBALDEHYDE COMPOUND AND PHARMACEUTICAL COMPOSITION, CONTAINING SAME, FOR IRE1ALPHA INHIBITION | Hanmi Pharm. Co., Ltd. (KR) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024072110-A1 | NOVEL TRICYCLIC HETEROCYCLIC CARBALDEHYDE COMPOUND AND PHARMACEUTICAL COMPOSITION, CONTAINING SAME, FOR IRE1α INHIBITION | 한미약품 주식회사 | 2024-04-04 | — | — | WO | disclosed |
| EP-3030565-B1 | NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS | GRUENENTHAL GMBH (DE) | 2017-07-19 | — | — | EP | disclosed |
| US-9688683-B2 | Substituted condensed pyrimidine compounds | Grünenthal GmbH (DE) | 2017-06-27 | — | — | US | disclosed |
| US-20160152624-A1 | NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS | Grünenthal GmbH (DE) | 2016-06-02 | — | — | US | disclosed |
| US-20040019046-A1 | Phenylacetamido-pyrazole derivatives and their use as antitumor agents | PHARMACIA ITALIA SPA (IT) | 2004-01-29 | — | — | US | disclosed |
| EP-1345909-A1 | PHENYLACETAMIDO-PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | Pharmacia Italia S.p.A. (IT) | 2003-09-24 | — | — | EP | disclosed |
| EP-1155014-B1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA AB (SE) | 2003-06-04 | — | — | EP | disclosed |
| WO-2002048114-A1 | PHENYLACETAMIDO- PYRAZOLE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS | PHARMACIA ITALIA S.P.A. (IT) | 2002-06-20 | — | — | WO | disclosed |
| EP-1155014-A1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | Pharmacia AB (SE) | 2001-11-21 | — | — | EP | disclosed |
| WO-2000043387-A1 | NEW BENZIMIDAZOLE COMPOUNDS FOR USE AS ACTIVE THERAPEUTIC SUBSTANCES, PROCESS FOR THE PREPARATION OF THESE COMPOUDNS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | PHARMACIA AB (SE) | 2000-07-27 | — | — | WO | disclosed |
| US-5225516-A | POLYMERS | THE GENERAL ELECTRIC COMPANY, P.L.C. (GB) | 1993-07-06 | — | — | US | disclosed |
| EP-0401532-B1 | PROCESS FOR THE PREPARATION OF A STORAGE STABLE LEVULINIC ACID | Chemie Linz Gesellschaft m.b.H. (AT) | 1993-03-24 | — | — | EP | disclosed |
| EP-0299205-B1 | SUSTAINED RELEASE MICROCAPSULES AND METHOD FOR THE PRODUCTION THEREOF | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM HIGHER EDUCATION (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0430510-A2 | Polymers | THE GENERAL ELECTRIC COMPANY, p.l.c. (GB) | 1991-06-05 | — | — | EP | disclosed |
| EP-0401532-A1 | Process for the preparation of a storage stable levulinic acid | Chemie Linz Gesellschaft m.b.H. (AT) | 1990-12-12 | — | — | EP | disclosed |
| EP-0299205-A1 | Sustained release microcapsules and method for the production thereof | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM HIGHER EDUCATION (US) | 1989-01-18 | — | — | EP | disclosed |
| US-4187225-A | Novel synthesis of bis pyrazolone oxonol dyes | POLAROID CORPORATION (US) | 1980-02-05 | — | — | US | disclosed |
| US-3933798-A | Novel bis-pyrazolone oxonol dyes | POLAROID CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160152624-A1 | NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS | PDE4A, PDE4B, TYMP | HSPD1 2415/4885BLM 242/4885HSPE1 2461/4885 |
| US-20040019046-A1 | Phenylacetamido-pyrazole derivatives and their use as antitumor agents | DCK, CCNK, CDK2 | HSPD1 524/4885BLM 2847/4885HSPE1 508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.